Biological Effects and Markers of Exposure to Xenosteroids and Selective Estrogen Receptor Modulators (SERMs) at the Hypothalamic-Pituitary Unit

  • M. Tena-Sempere
  • E. Aguilarl
Conference paper
Part of the Research and Perspectives in Endocrine Interactions book series (RPEI)


Estrogen is a pivotal factor in the regulation of a wide array of biological systems, in both the male and the female, which include not only the reproductive axis but also bone, the cardiovascular system, adipose tissue and the brain. In recent years, the biological effects and mechanisms of action of estrogen have been deeply revisited, and extensive efforts have been made to better understand both the physiology and pathophysiology of estrogen actions in different target tissues. In this context, a major concern has recently emerged about the potential deleterious effects on human and wildlife health of a wide array of natural and synthetic compounds with sex steroid-like (mostly estrogenic) bioactivities; these compounds are globally termed xenosteroids. In addition, synthetic drugs have been developed with combined estrogenic and anti-estrogenic actions, depending on the cellular context. These molecules, collectively named selective estrogen receptor modulators (SERMs), are provided with obvious pharmacological applications, but they may also serve in the characterization of the complex mode of action of estrogen in different physiological systems. Similarly, estrogen receptor (ER)-selective ligands have been recently identified or engineered, thus providing an experimental tool to dissect out the contribution of each of the two major ER isoforms (ERot and ERP) in signaling the plethora of estrogen effects in multiple target tissues. The hypothalamic- pituitary (HP) unit is highly sensitive to the actions of estrogen, although several aspects of estrogen effects upon the development and regulation of the HP unit remain partially unknown. The aim of this review is to provide a comprehensive overview of our recent work in the identification of molecular mechanisms and markers of exposure to xenoestrogens, as well as in the analysis of the biological effects of SERMs and ER-selective ligands at the HP unit.


Estrogen Receptor Estradiol Benzoate Neonatal Exposure Estradiol Benzoate Antiestrogenic Action 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Avioli LV (1999) SERM drugs for the prevention of osteoporosis. Trends Endocrinol Metab 10:317–319.CrossRefPubMedGoogle Scholar
  2. Boisen KA, Main KM, Rajpert-De Meyts E, Skakkebaek NE (2001) Are male reproductive disorders a common entity? The testicular dysgenesis syndrome. Ann NY Acad Sci 948:90–99.PubMedGoogle Scholar
  3. Clark JH, Mani SK (1994) Actions of ovarian steroids. In: Knobil E, Neill JD (eds) The physiology of reproduction. Raven Press, New York, pp 1011–1062. Döhler KD, Hancke JL (1978) Thoughts on the mechanisms of sexual brain differentiation. In: Dorner G, Kawakami M (eds) Hormones and brain development. Elsevier, Amsterdam, pp 153–158.Google Scholar
  4. Frasor J, Barnett DH, Danes JM, Hess R, Parlow AF, Katzenellengogen BS (2003) Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) α activity by ERβ in the uterus. Endocrinology 144:3159–3166CrossRefPubMedGoogle Scholar
  5. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS (2003) Activities of estrogen receptor alpha-and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 206:13–22.CrossRefPubMedGoogle Scholar
  6. Harris HA, Katzenellenbogen JA, Katzenellenbogen BS (2002) Characterization of the biological roles of estrogen receptors, ERα and ERβ, in estrogen target tissues in vivo through the use of an ERα-selective ligand. Endocrinology 143:4172–4177.CrossRefPubMedGoogle Scholar
  7. Jordan VC, Morrow M (1999) Tamoxifen, raloxifene and the prevention of breast cancer. Endocrinol Rev 20:253–278.CrossRefGoogle Scholar
  8. Kuiper GGJM, Shughrue PJ, Merchenthaler I, Gustafsson J-A (1998) The estrogen receptor β subtype: A novel mediator of estrogen actions in neuroendocrine systems. Frontiers Neuroendocrinol 19:253–286.CrossRefGoogle Scholar
  9. MacLusky NJ, Naftolin F (1981) Sexual differentiation of the central nervous system. Science 211:1294–1302.PubMedGoogle Scholar
  10. McDonnell DP (1999) The molecular pharmacology of SERMs. Trends Endocrinol Metab 10:301–311.CrossRefPubMedGoogle Scholar
  11. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA (2001) Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44:4230–4251.CrossRefPubMedGoogle Scholar
  12. Österlund M, Kuiper GGJM, Gustafsson J-A, Hurd YL (1998) Differential distribution of estrogen receptor-α and-β mRNA within the female rat brain. Brain Res Mol Brain Res 54:175–180.CrossRefPubMedGoogle Scholar
  13. Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-A, Kushner PJ, Scanlan TS (1997) Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277:1508–1510.CrossRefPubMedGoogle Scholar
  14. Pinilla L, Gonzalez LC, Gaytan F, Tena-Sempere M, Aguilar E (2001a) Oestrogenic effects of neonatal administration of raloxifene on hypothalamic-pituitary-gonadal axis in male and female rats. Reproduction 121:915–924.CrossRefPubMedGoogle Scholar
  15. Pinilla L, Gonzalez LC, Tena-Sempere M, Aguilar E (2001b) Evidence for an estrogen-like action of raloxifene upon the hypothalamic-pituitary unit: raloxifene inhibits luteinizing hormone secretion and stimulates prolactin secretion in ovariectomized female rats. Neurosci Lett 311:149–152.CrossRefPubMedGoogle Scholar
  16. Pinilla L, Barreiro ML, Gonzalez LC, Tena-Sempere M, Aguilar E (2002a) Comparative effects of testosterone propionate, oestradiol benzoate, ICI 182,780, tamoxifen and raloxifene on hypothalamic differentiation in the female rat. J Endocrinol 172:441–448.CrossRefPubMedGoogle Scholar
  17. Pinilla L, Barreiro ML, Tena-Sempere M, Aguilar E (2002b) Raloxifene effects upon the neuronal system controlling sexual receptivity in female rats. Neurosci Lett 329:285–288.CrossRefPubMedGoogle Scholar
  18. Quadros PS, Pfau JL, Goldstein AY, De Vries GJ, Wagner CK (2002) Sex differences in progesterone receptor expression: a potential mechanism for estradiol-mediated sexual differentiation. Endocrinology 14310:3727–3739.CrossRefGoogle Scholar
  19. Rajapakse N, Silva E, Kortenkamp A (2002) Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action Environ Health Perspect 110:917–921.PubMedGoogle Scholar
  20. Reibel S, Andre V, Chassagnon S, Andre G, Marescaux C, Nehlig A, Depaulis A (2000) Neuroprotective effects of chronic estradiol benzoate treatment on hippocampal cell loss induced by status epilepticus in the female rat. Neurosci Lett 281:79–82.CrossRefPubMedGoogle Scholar
  21. Schneider LS, Finch CE (1997) Can estrogens prevent neurodegeneration. Drugs Aging 11:87–95.PubMedGoogle Scholar
  22. Schreihofer DA, Stoler MH, Shupnik MA (2000) Differential expression and regulation of estrogen receptors (ERs) in rat pituitary and cell lines: Estrogen decreases ERa protein and estrogen responsiveness. Endocrinology 141:2174–2184.CrossRefPubMedGoogle Scholar
  23. Sharpe RM (1998) The roles ofoestrogen in the male. Trends Endocrinol Metab 9:371–377.CrossRefGoogle Scholar
  24. Shupnik MA (2002) Oestrogen receptors, receptor variants and oestrogen actions in the hypothalamic-pituitary axis. J Neuroendocrinol 14:85–94.CrossRefPubMedGoogle Scholar
  25. Silva E, Rajapakse N, Kortenkamp A (2002) Something from “nothing”: eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ Sci Technol 36:1751–1756.CrossRefPubMedGoogle Scholar
  26. Somjen D, Waisman A, Kaye AM (1996) Tissue selective action of tamoxifen methiodide, raloxifene and tamoxifen on creatine kinase B activity in vitro and in vivo. J Steroid Biochem Mol Biol 59:389–396CrossRefPubMedGoogle Scholar
  27. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen BS, Katzenellenbogen JA (2000) Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-a-selective agonists. J Med Chem 43:4934–4947.CrossRefPubMedGoogle Scholar
  28. Tena-Sempere M, Navarro J, Pinilla L, Gonzalez LC, Huhtaniemi I, Aguilar E (2000a) Neonatal exposure to estrogen differentially alters estrogen receptor α and β messenger ribonucleic acid expression in rat testis during postnatal development. J Endocrinol 165:345–357.CrossRefPubMedGoogle Scholar
  29. Tena-Sempere M, Pinilla L, Gonzalez LC, Aguilar E (2000b) Reproductive disruption by exposure to exogenous estrogenic compounds during sex differentiation: lessons from the neonatally estrogenized male rat. Curr Topics Steroid Res 3:23–37.Google Scholar
  30. Tena-Sempere M, Gonzalez LC, Pinilla L, Huhtaniemi I, Aguilar E (2001a) Neonatal imprinting and regulation of estrogen receptor alpha and beta mRNA expression by estrogen in the pituitary and hypothalamus of the male rat. Neuroendocrinology 73:12–25.CrossRefPubMedGoogle Scholar
  31. Tena-Sempere M, Barreiro ML, Gonzalez LC, Pinilla L, Aguilar E (2001b) Differential neonatal imprinting and regulation by estrogen of estrogen receptor subtypes α and β and of the truncated estrogen receptor product (TERP-1) mRNA eexpression in the male rat pituitary. Neuroendocrinology 74:347–358.CrossRefPubMedGoogle Scholar
  32. Tena-Sempere M, Barreiro ML, Aguilar E, Pinilla L (2003a) Mechanisms for altered reproductive function in female rats following neonatal administration of raloxifene. Eur J Endocrinol, 150:397–403.CrossRefGoogle Scholar
  33. Tena-Sempere M, Navarro VM, Mayen A, Bellido C, Sanchez-Criado JE (2003b) Regulation of estrogen receptor (ER) isoform messenger RNA expression by different ER ligands in female rat pituitary. Biol Reprod 2004; 70:671–678.CrossRefGoogle Scholar
  34. White R, Parker MG (1998) Molecular mechanisms of steroid hormone action. Endocr Relat Cancer 5:1–14.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • M. Tena-Sempere
    • 1
  • E. Aguilarl
    • 1
  1. 1.Department of Cell Biology, Physiology and ImmunologyUniversity of CórdobaCórdobaSpain

Personalised recommendations